Characterization of intestinal disease associated with human immunodeficiency virus infection and response to antiretroviral therapy.
about
Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infectedEarly antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regenerationLong-term treatment of NZB mice with anti-CD4 results in wasting disease, lymphoid atrophy and chronic diarrhea.Tropical malabsorption.HIV infection and the gastrointestinal immune systemImpaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ARTDifferential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.Review article: the aetiology, investigation and management of diarrhoea in the HIV-positive patient.Immunodiscordant responses to HAART--mechanisms and consequences.
P2860
Q28741704-CF86DF92-DFE8-4989-BE5A-D8A6D724C62FQ33835422-88F0D3E9-D90D-4B1E-82BC-9F32B88DAA08Q34503669-37ABB567-7BB8-4795-9D7D-413850B8021DQ34587941-EF3CD77C-92DD-4976-AB5A-38B54BC8E3A8Q34601874-0F89BD62-DCAD-4144-BB45-E53BB013E3CAQ35626699-462E5BFB-2101-46B6-995A-52055505BE67Q36915902-CCB49C65-18D4-4990-A643-580530A431E4Q37903384-7DBD7418-F225-4A09-9A52-4DF70F336B89Q38156230-C5CAF5E1-A042-47F7-B4AC-761B73FE95AA
P2860
Characterization of intestinal disease associated with human immunodeficiency virus infection and response to antiretroviral therapy.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Characterization of intestinal ...... nse to antiretroviral therapy.
@ast
Characterization of intestinal ...... nse to antiretroviral therapy.
@en
Characterization of intestinal ...... nse to antiretroviral therapy.
@nl
type
label
Characterization of intestinal ...... nse to antiretroviral therapy.
@ast
Characterization of intestinal ...... nse to antiretroviral therapy.
@en
Characterization of intestinal ...... nse to antiretroviral therapy.
@nl
prefLabel
Characterization of intestinal ...... nse to antiretroviral therapy.
@ast
Characterization of intestinal ...... nse to antiretroviral therapy.
@en
Characterization of intestinal ...... nse to antiretroviral therapy.
@nl
P2860
P356
P1476
Characterization of intestinal ...... nse to antiretroviral therapy.
@en
P2093
P2860
P304
P356
10.1086/314803
P407
P478
179 Suppl 3
P577
1999-05-01T00:00:00Z